Hepatitis B virus (HBV) genotype and its correlation with Hepatocellular carcinoma

Phan Quoc Viet; Ho Thi Thanh Thuy

6 (1) 2016

Hepatitis B virus (HBV) genotype and its correlation with Hepatocellular carcinoma

Author - Affiliation:

Phan Quoc Viet - Viet ATechnology Corporation , Vietnam

Ho Thi Thanh Thuy - Viet ATechnology Corporation , Vietnam

Corresponding author: Phan Quoc Viet - htthuy80@yahoo.com

Abstract

Hepatitis B is a viral disease caused by Hepatitis B Virus (HBV), which could cause both acute and chronic infection. HBV infection have been considered as the most common high risk factor that cause cirrhosis and subsequent development of Hepatocellular (HCC) worldwide.
Even though Hepatitis B vaccine was found to be generally safe for two decades, however, HBV infection continues to be a major public health worldwide with the death raising from 600.000 to 1 million cases. Many risk factors, including HBV genotypes, have been proved to be associated to the chronic development and, then development of HCC.
Current review was carried out to summarize the properties and prevalence of HBV genotypes, based on Vietnamese population, in order to highlight characteristic of HBV infection, simultaneously analyzed the correlation between HBV genotypes and other high risk factor related to HCC development.

Keywords

Hepatitis B; HBV, genotype; Vietnamese population.

Full Text:

PDF

References

Buti, M., Cotrina, M., Valdes, A., Jardi, R., Rodriguez-Frias, F., Esteban, R. (2002). Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?, J. Hepatol., 36, 445–446.

Chan, H. L., Tsang, S. W., Wong, M. L., Tse, C. H., Leung, N. W., Chan, F. K., Sung, J. J. (2002). Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong, Am J Gastroenterol., 97, 2629-2633.

Chan, H. L.-Y., Wong, M. L., Hui, A. Y., Hung, L. C.-T., Chan, F. K.-L., & Sung, J. J.-Y. (2003). Hepatitis B Virus Genotype C Takes a More Aggressive Disease Course Than Hepatitis B Virus Genotype B in Hepatitis B e Antigen-Positive Patients, Journal of Clinical Microbiology, 41(3), 1277–1279.

Chan, H. L.-Y., Wong, M.-L., Hui, A. Y., Chim, A. M.-L., Tse, A. M.-L., Hung, L. C.-T.,… Sung, J. J.-Y. (2003). Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment, World Journal of Gastroenterology : WJG, 9(12), 2695–2697.

Chien, R. N., Yeh, C. T., Tsai, S. L., Chu, C. M., Liaw, Y. F. (2003). Determinants for sustained HBeAg response to lamivudine therapy, Hepatology, 38, 1267–1273.

Chu, C. J., Hussain, M., Lok, A. S. (2002). Hepatitis B virus geneotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus geneotype C, Hepatology, 122, 1756-1762.

Chu, C. J., Keeffe, E. B., Han, S. H., Perrillo, R. P., Min, A. D., Soldevila-Pico, C. (2003). Prevalence of HBV precore/core promoter variants in the United States, Hepatology. 38, 619-628.

Ding, X., Mizokami, M., Yao, G., Xu, B., Orito, E., Ueda, R. (2001). Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai Chin, Intervirology, 44, 43-47.

Do Thi Thuy Duong and Le Huyen Ai Thuy. (2010). Application of Real-time PCR in genotyping HBV at Daklak, Journal of Science, 1(19)-2011, 118-123 (in Vietnamese).

Dong Thi Hoai An, Cao Minh Nga. (2003). Genotyping Hepatitis B virus by Multiplex PCR in chronic HBV infected patients, From Molecular Science to Life and Health Care, 17-25 (in Vietnamese).

Dunford, L., Carr, M. J., Dean, J., Nguyen, L. T., Ta Thi, T. H., Nguyen, B. T., … Thi, L. A. N. (2012). A Multicentre Molecular Analysis of Hepatitis B and Blood-Borne Virus Coinfections in Viet Nam, PLoS ONE, 7(6), e39027.

Erhardt, A., Reineke, U., Blondin, D., Gerlich, W. H., Adams, O., Heintges, T., Niederau, C., Häussinger, D. (2000). Mutation of the core promoter and response to interferon in chronic replicative hepatitis B, Hepatology., 31:716-725.

Ho Tan Dat, Pham Thi Thu Thuy, Nguyen Bao Toan, Nguyen Thi Kieu Oanh, Nguyen Thanh Tong. Medic Medical Center, HoChiMinh city. Application of Sequencing to genotyping and NUCs drug resistant mutations of HBV. Quote from http://www.drthuthuy.com/reseach/HBVGenotype.html (in Vietnamese).

Hou, J, Yin, Y. K., Xu, D., Tan, D., Niu, J., Zhou, X., Wang, Y., Zhu, L., He, Y., Ren, H., Wan, M., Chen, C., Wu, S., Chen, Y., Xu, J., Wang, Q., Wei, L., Chao, G., Constance, B. F., Harb, G., Brown, N. A., Jia, J. (2008). Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: results at 1 year of a randomized, double-blind trial, Hepatology, 47, 447–454.

Hsieh, T. H., Tseng, T. C., Liu, C. J., Lai, M. Y., Chen, P. J., Hsieh, H. L., Chen, D. S., Kao, J. H. (2009). Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C, Antivir. Ther., 14, 1157–1163.

Janssen, H. L., Flink, H. J., Zonneveld, M. .V., Niesters, H. G., Man, R. A. D., Schalm, S. W. (2004). HBeAg seroconversion in chronic HBV patients treated with pegylated interferon alfa-2b alone or in combination with lamivudine: the role of HBV geneotype, Hepatology., 40, 660A.

Kao Jia-Horng. (2011). Molecular Epidemiology of Hepatitis B virus, Korean J Intern Med., 26, 255-261.

Kao, J. H., Chen, P. J., Lai, M. Y., Chen, D. S. (2000). Hepatitis B geneotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology, 118, 554-559.

Kao, J. H., Chen, P. J., Lai, M. Y., Chen, D. S. (2004). Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers, J. Med. Virol., 72, 363–369.

Kao, J. H., Liu, C. J., Chen, D. S. (2002). Hepatitis B viral geneotypes and lamivudine resistance, J Hepatol., 36, 303-304.

Kao, J. H., Wu, N. H., Chen, P. J., Lai, M. Y., Chen, D. S. (2000). Hepatitis B genotype and the response to interferon therapy, J Hepatol., 33, 998-1002

Kao, J.-H., Chen, P.-J., Lai, M.-Y., & Chen, D.-S. (2002). Genotypes and Clinical Phenotypes of Hepatitis B Virus in Patients with Chronic Hepatitis B Virus Infection, Journal of Clinical Microbiology, 40(4), 1207–1209.

Kumar, A., Kumar, S. I., Pandey, R., Naik, S., Aggarwal, R. (2005). Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype, Indian J Gastroenterol., 24, 19-22.

Lao Duc Thuan, Mai Ngoc Lanh, Le Thi Phuong, Phan Van Be Bay, Ho Thi Thanh Thuy, Truong Kim Phuong, Le Huyen Ai Thuy. (2014). Application of Real-time PCR in genotyping, viral load identifying, and characterizing NUCs drug resistant mutations at Dong Thap Hospital, Journal of Science, 6(39), 67-75 (in Vietnamese).

Lin, C. L., Kao, J. H. (2011). The clinical implications of hepatitis B virus genotype: Recent advances, Journal of Gastroenterology and Hepatology, 26Suppl 1, 123–130.

Lindh, M., Hannoun, C., Dhillon, A. P., Norkrans, G., Horal, P. (1999). Core promoter mutations and geneotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers, J Infect Dis., 179, 775-782.

Lurie, Y., Manns, M. P., Gish, R. G. (2005). The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naive, HBeAg (+) and HBeAg (-) patients with chronic hepatitis B, J. Hepatol., 42 (Suppl. 2), 184.

Neuveut, C., Wei, Y., Buendia, M. A. (2010). Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol., 52(4), 594-604.

Nguyen, C. H., Ishizaki, A., Chung, P. T., Hoang, H. T., Nguyen, T. V., Tanimoto, T., Lihana, R., Matsushita, K., Bi, X., Pham, T. V., Ichimura, H. (2011). Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam, J Med Virol., 83(3), 399-404.

Nguyen, L. H., Ha, N. B., Vutien, P., Ha, N. B., Garcia, R. T., Trinh, H. N., Nguyen, M. H. (2009). Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatology International, 3(3), 461–467.

Ni, Y. H., Chang, M. H., Wang, K. J., Hsu, H. Y., Chen, H. L., Kao, J. H., Yeh, S. H., Jeng, Y. M., Tsai, K. S., Chen, D. S. (2004). Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma, Gastroenterology, 127, 1733–1738.

Norder, H., Courouce, A. M., Magnius, L. O. (1998). Complete genome, phylogenetic relatedness and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes, Virology, 198(4), 89-503.

Norder, H., Hammas, B., Lee, S. D., Bele, C., Courouce, A. M., Mushawar, I. K, Bile, K., Magnius, L. O. (1993). Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variation in the primary structure of the surface gene, J. Gen .Virol., 74, 1341-1348.

Norio, A. and Hiromitsu, K. (2005). Influence of hepatitis B virus geneotypes on the response to antiviral therapies, Journal of Antimicrobial Chemotherapy, 55, 139–142.

Okamoto, H., Tsuda, F., Sakagawa, H., Sastrosoewignjo, R. I., Imai, M., Miyakawa, Y. (1988). Typing hepatitis B virus by homology in nucleotide sequence comparison of surface antigen subtypes, J. Gen .Virol., 69, 2575-2583.

Oyagbemi, A. A., Azeez, O. I., Saba A. B. (2010). Hepatocellular carcinoma and the underlying mechanisms. Afr Health Sci., 10(1), 93-98.

Phung, T. B., Alestig, E., Nguyen, T. L., Hannoun, C., Lindh, M. (2010). Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam-genotypes B4 and C1 predominate. J Med Virol., 82(8), 1327-1333.

Raimondi, S., Maisonneuve, P., Bruno, S., Mondelli, M. U. (2010). Is response to antiviral treatment influenced by hepatitis B virus genotype?, J.Hepatol., 52, 441–449.

Ren, X., Xu, Z., Liu, Y., Li, X., Bai, S., Ding, N., … Xu, D. (2010). Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-onchronic liver failure without pre-existing liver cirrhosis, Journal of Viral Hepatitis, 17(12), 887–895.

Sakugawa, H., Nakasone, H., Nakayoshi, T., Orito, E., Mizokami, M., Yamashiro, T. (2002). Preponderance ofhepatitis B virus geneotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan, J Med Virol., 67, 484-489.

Shiina, S., Fujino, H., Uta, Y., Tagawa, K., Unuma, T., Yoneyama, M. (1991). Relationship of HBeAg subtypes with HBeAg/anti-HBe status and chronic liver disease Part I: Analysis of 1744 HBeAg carriers, Am J Gastroenterol., 86, 866-871.

Sinn, D. H., Lee, J., Goo, J., Kim, K., Gwak, G. Y., Paik, Y. H., Choi, M. S., Lee, J.

H., Koh, K. C., Yoo, B. C., Paik, S. W. (2015). Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load. Hepatology., 62(3), 694-701.

Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T. (2003). Influence of hepatitis B virus geneotypes on the progression of chronic type B liver disease, Hepatology, 7, 19-26.

Thakur, V., Guptan, R. C., Kazim, S. N., Malhotra, V., Sarin, S. K. (2002). Profile, spectrum and significance of HBV genotype in chronic liver disease patients in the Indian subcontinent, J Gastroenterol Hepatol., 17, 165-170.

Thakur, V., Sarin, S. K., Rehman, S., Guptan, R. C., Kazim, S. N., Kumar, S. (2005). Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B, Indian J Gastroenterol., 24, 12-1.

Tran, H. T., Ushijima, H., Quang, V. X., Phuong, N., Li, T. C., Hayashi, S., Xuan Lien, T., Sata, T., Abe, K. (2003). Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam, Hepatol Res., 26(4), 275-280.

Truong Kim Phuong, Lao Duc Thuan, Ho Thi Thanh Thuy, Lieu Chi Hung, Le Huyen Ai Thuy. (2013). Application of Real-time PCR in genotyping, viral load identifying, and characterizing NUCs drug resistant mutations at Tay Ninh Hospital, Proceedings of National Conference in Biotechnology, the South Viet Nam, 176 (in Vietnamese).

Westland, C., Delaney, W. 4th, Yang, H., Chen, S. S., Marcellin, P., Hadziyannis, S., Gish, R., Fry, J., Brosgart, C., Gibbs, C., Miller, M., Xiong, S. (2003). Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil, Gastroenterology, 125, 107–116.

Wiegand, J., Hasenclever, D., Tillmann, H. L. (2008). Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence, Antivir. Ther., 13, 211–220.

Yang, H. I., Yeh, S. H., Chen, P. J., Iloeje, U. H., Jen, C. L., Su, J., Wang, L. Y., Lu, S. N., You, S. L., Chen, D. S., Liaw, Y. F., Chen, C. J.; REVEAL-HBV Study Group. (2008). Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma, J. Natl. Cancer Inst., 100, 1134–1143.

Yin, J., Zhang, H., Li, C., Gao, C., He, Y., Zhai, Y., Zhang, P., Xu, L., Tan, X., Chen, J., Cheng, S., Schaefer, S., Cao, G. (2008). Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area, Carcinogenesis, 29, 1685–1691.

Yu, M. W., Yeh, S. H., Chen, P. J., Liaw, Y. F., Lin, C. L., Liu, C. J., Shih, W. L., Kao, J. H., Chen, D. S., Chen, C. J. (2005). Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men, J. Natl. Cancer Inst., 97, 265–72.

Yuen, M. F., Wong, D. K., Sablon, E., Yuan, H. J., Sum, S. M., Hui, C. K., Chan, A. O., Wang, B. C., Lai, C. L. (2003). Hepatitis B virus genotypes B and C do not affect the antiviral response to Lamivudine, Antivir. Ther., 8, 531–534.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.